We found that ponatinib significantly inhibited NB cell proliferation and induced cell apoptosis in these NB cell lines by blocking FGFR1-activated PI3K/AKT/mTOR and JAK/STAT3 signal pathways. Here, FGFR1 is linked to neuroblastoma.